Viking Therapeutics (VKTX) Shares Repurchased (2014 - 2022)

Viking Therapeutics' (VKTX) quarterly Shares Repurchased came in at $1.7 million in Q2 2022, down 67.31% quarter-over-quarter from $5.1 million in Q1 2022.

Viking Therapeutics (VKTX) Shares Repurchased (2014 - 2022) Analysis & Trends

Viking Therapeutics has disclosed Shares Repurchased across 2 years of filings, most recently posting $1.7 million for Q2 2022.

  • Shares Repurchased for Q2 2022 came in at $1.7 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $6.8 million (changed N/A YoY), and the FY2022 annual result was $6.8 million, changed N/A from the prior year.
  • Shares Repurchased came in at $1.7 million for Q2 2022 at Viking Therapeutics, down from $5.1 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $5.1 million in Q1 2022 to a low of $1.7 million in Q2 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 839,896.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 336.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Viking Therapeutics 3.50 Bn 3.50 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 1.67 Mn
Jun 30, 2022 1.67 Mn
Mar 31, 2022 5.12 Mn
Mar 31, 2022 5.12 Mn
Dec 31, 2014 4.00
Dec 31, 2014 4.00
Sep 30, 2014 -2,498.00
Sep 30, 2014 -2,498.00
Jun 30, 2014 2,494.00
Jun 30, 2014 2,494.00
Mar 31, 2014 2.00
Mar 31, 2014 2.00